Trial
NCT01262274
Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Collaborators
Department of breast and endocrine surgery graduate school of Medicine Osaka University
Condition
Breast Neoplasms
Intervention
Anastrozole
Why stopped
Due to an adverse event revelation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-21